Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1989-8-22
|
pubmed:abstractText |
The Hodgkin-associated Ki-1 antigen occurs in two different molecular forms. The 120-kDa membrane-associated form is a phosphorylated glycoprotein, which is derived from a non-phosphorylated intracellular 84-kDa apoprotein that is co-translationally N-glycosylated with a carbohydrate portion of 6 kDa. The other form of the Ki-1 antigen is a non-glycosylated phosphoprotein of 57 kDa which only occurs intracellularly. Both forms of the antigen are phosphorylated at serine residues. Enzymatic cleavage with sialidase reduced the 120-kDa membrane antigen by about 15 kDa, while its 90-kDa precursor and the 57-kDa intracellular form of the Ki-1 antigen remained unaltered. Pulse-chase experiments revealed that the 57-kDa and 90/120-kDa molecules are synthesized independently of each other. Four to eight hours after synthesis, the degradation of the 120-kDa molecule to a 105-kDa membrane-associated intermediate begins. This is further processed and appears in the cell supernate as a 90-kDa molecule. Hodgkin's disease-derived, Epstein-Barr virus-transformed cell lines and the acute T cell leukemia line MOLT-4 contain both forms of the Ki-1 antigen, whereas only the 57-kDa intracellular antigen is expressed in U266/B1 myeloma cells, in the Burkitt lymphoma cell lines Raji and Daudi and in acute promyelocytic HL-60 leukemia cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD30,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Neuraminidase
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0177-3593
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
370
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
409-16
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2545229-Amino Acids,
pubmed-meshheading:2545229-Antigens, CD30,
pubmed-meshheading:2545229-Antigens, Differentiation,
pubmed-meshheading:2545229-Antigens, Neoplasm,
pubmed-meshheading:2545229-Cell Membrane,
pubmed-meshheading:2545229-Glycosylation,
pubmed-meshheading:2545229-Hodgkin Disease,
pubmed-meshheading:2545229-Humans,
pubmed-meshheading:2545229-Neuraminidase,
pubmed-meshheading:2545229-Phosphorylation,
pubmed-meshheading:2545229-Precipitin Tests,
pubmed-meshheading:2545229-Tumor Cells, Cultured
|
pubmed:year |
1989
|
pubmed:articleTitle |
The Hodgkin-associated Ki-1 antigen exists in an intracellular and a membrane-bound form.
|
pubmed:affiliation |
Biochemisches Institut der Medizinischen Fakultät der Universität Kiel.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|